Under normal conditions, p53 downregulates TfR1, promotes the expression of ferritin and HEPC, and suppresses IRPs, mechanisms that collectively reduce intracellular iron availability and inhibit tumor growth [62,63]. This evidence concerns the gene TFRC and neoplasm.